Where is insulin produced
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Insulin Production: Key Insights from Recent Research
Insulin Production in the Pancreas
Pancreatic Beta Cells
Insulin is primarily produced by the beta cells located in the islets of Langerhans within the pancreas. The process begins with the synthesis of pre-proinsulin, which is then converted to proinsulin. Proinsulin undergoes further proteolytic processing to form mature insulin and C-peptide, which are stored in secretory granules until they are released into the bloodstream . This mechanism is crucial for maintaining glucose homeostasis in the body.
Insulin Secretory Granules
In the pancreas, insulin is stored in vesicles known as insulin secretory granules (ISGs). These granules play a vital role in the regulated secretion of insulin in response to glucose levels. Defects in ISG production and secretion are linked to conditions such as Type 2 diabetes, where insulin resistance and beta-cell dysfunction are prevalent.
Extrapancreatic Insulin Production
Choroid Plexus in the Brain
Recent studies have revealed that insulin is also produced in the choroid plexus (ChP) of the brain. The epithelial cells of the ChP synthesize and release insulin, a process regulated by serotonergic signaling rather than glucose. This discovery highlights a novel site of insulin production outside the pancreas, suggesting a potential role in neuroregulation and brain function.
Cerebral Cortex and Hippocampus
Insulin synthesis has also been identified in neurons within the cerebral cortex and neural progenitor cells of the hippocampus. This local production of insulin supplements the slower supply from pancreatic beta cells, providing a rapid means of regulating synaptic transmission and energy homeostasis in neural networks. This mechanism could have therapeutic implications for conditions like diabetes, obesity, and neurodegenerative diseases.
Other Organs and Tissues
In diabetic models, insulin-producing cells have been found in various organs such as the liver, adipose tissue, spleen, and bone marrow. These cells express insulin mRNA and protein, indicating active insulin synthesis. This extrapancreatic production of insulin suggests a broader physiological role and potential avenues for diabetes treatment through the generation of insulin-producing cells from different tissues.
Recombinant Insulin Production
Bacterial and Yeast Systems
Recombinant DNA technology has enabled the production of human insulin using bacterial systems like Escherichia coli and yeast such as Saccharomyces cerevisiae. These systems are employed to meet the growing demand for insulin, especially given the increasing prevalence of diabetes. The production involves the synthesis of insulin chains, which are then combined to form active insulin. This method has proven to be efficient and cost-effective for large-scale insulin production .
Plant-Based Systems
Transgenic plants are emerging as a promising alternative for insulin production. These plants can produce high levels of biologically active proinsulin in seeds or leaves, offering a low-cost and scalable method for insulin production. This approach could significantly reduce the cost of insulin, making it more accessible for therapeutic use.
Conclusion
Insulin production is a complex process primarily occurring in the pancreatic beta cells, but recent research has uncovered additional sites of production in the brain and other tissues. Advances in recombinant DNA technology and transgenic plant systems are paving the way for more efficient and cost-effective insulin production methods. These insights not only enhance our understanding of insulin biosynthesis but also open new avenues for diabetes treatment and management.
Sources and full results
Most relevant research papers on this topic